Results 121 to 130 of about 29,640 (301)

Corneal biomechanical changes in allergic conjunctivitis [PDF]

open access: diamond, 2021
Qian Wang   +6 more
openalex   +1 more source

Assessing the painful, uninflamed eye in primary care [PDF]

open access: yes, 2015
We acknowledge the important contributions of Professor Amada J Lee, University of Aberdeen, Division of Statistics, for assistance with analysing the data from the patient survey.
Dick, Andrew   +2 more
core   +1 more source

Efficacy of up to 4 years of tralokinumab in adults with moderate‐to‐severe atopic dermatitis

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
AD is a relapsing and remitting skin disease often requiring long‐term treatment. We assessed the long‐term efficacy of tralokinumab in adults with moderate‐to‐severe AD consistently treated for up to 4 years. Treatment with tralokinumab plus optional TCS/TCI provided substantial improvements in AD signs and symptoms, and these improvements were ...
Melinda Gooderham   +13 more
wiley   +1 more source

Allergic conjunctivitis in Asia [PDF]

open access: yesAsia Pacific Allergy, 2017
Allergic conjunctivitis (AC), which may be acute or chronic, is associated with rhinitis in 30%-70% of affected individuals, hence the term allergic rhinoconjunctivitis (AR/C). Seasonal and perennial AC is generally milder than the more chronic and persistent atopic and vernal keratoconjunctivitis.
openaire   +2 more sources

Prevalence of allergic conjunctivitis: a missed opportunity? [PDF]

open access: bronze, 2009
Carlos Antônio Riedi   +1 more
openalex   +1 more source

A survey on features of allergic rhinitis in children [PDF]

open access: yes, 2013
Objective: A number of epidemiologic studies evaluated the prevalence of allergic rhinitis (AR), but few data are available on its different clinical presentations.
),   +11 more
core   +1 more source

Biomarkers for therapeutic response and adverse outcomes in atopic dermatitis: A systematic review

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This review assessed 52 biomarkers predicting systemic therapy response and adverse events in atopic dermatitis. Most studies focused on dupilumab, and findings were inconsistent. IgE and eosinophils were largely non‐predictive, though elevated eosinophils and LDH sometimes indicated poorer outcomes.
Eva Hilger   +11 more
wiley   +1 more source

Immunomodulatory Effects of Galectin-1 on an IgE-Mediated Allergic Conjunctivitis Model [PDF]

open access: hybrid, 2015
C.B. Mello   +5 more
openalex   +1 more source

Brazilian guidelines for the monitoring and treatment of pediatric allergic conjunctivitis

open access: diamond, 2021
Cristiana Ronconi   +9 more
openalex   +1 more source

Impact of socioeconomic and environmental factors on atopic eczema and allergic rhinitis: a cross sectional study [PDF]

open access: yes, 2015
The prevalence of allergic rhinitis and atopic eczema is on the rise in recent decades. Many factors can be related to the development of these diseases.
Bitarafan, Niloofar   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy